Simplify Logo
C the Signs

C the Signs

AI cancer detection and referral platform

AI Data Engineer

Full-Time
No salary listed
Mid
Bachelor's, Master's
Remote in USA+1 more

More locations: Boston, MA, USA

Remote
H1B Sponsorship Available

About the job

Requirements
  • A bachelor's degree in Computer Science, Engineering, or a related field is required.
  • Proven experience as a Data Engineer with a focus on big data technologies is required.
  • Strong proficiency in Python, Scala, or Java is required.
  • Extensive experience with data warehousing, extract, transform, and load processes, and data modeling is required.
  • Experience with major cloud providers such as Amazon Web Services, Google Cloud Platform, or Microsoft Azure and their data storage and processing services is required.
  • Hands-on experience with big data frameworks such as Apache Spark for distributed processing is required.
  • The candidate must be able to solve problems and work independently and as part of a team.
  • Strong communication and interpersonal skills are required.
  • The candidate must be a United States citizen, Green Card holder, or currently in the United States with a valid H-1B visa.
Responsibilities
  • Collaborate with data scientists and machine learning engineers to understand data requirements for large language model and machine learning model fine-tuning.
  • Design, build, and maintain scalable data pipelines to ingest, process, and store massive and diverse healthcare datasets.
  • Implement data validation and monitoring to ensure the integrity, accuracy, and consistency of training datasets.
  • Implement data cleaning, validation, and transformation processes to ensure data quality and integrity.
  • Develop and optimize data structures and schemas for efficient access and utilization by large language models and machine learning models.
  • Identify and acquire new data sources while ensuring compliance with relevant healthcare regulations, including the Health Insurance Portability and Accountability Act.
  • Monitor data pipeline performance, troubleshoot issues, and implement optimizations to improve efficiency and reliability.
  • Document data engineering processes, data models, and data dictionaries.
  • Stay current with advancements in data engineering, big data technologies, and machine learning.
Desired Qualifications
  • A master's degree in a related field is preferred.
  • Experience with healthcare data and understanding of healthcare data standards such as Fast Healthcare Interoperability Resources and Health Level Seven International are preferred.
  • Familiarity with machine learning concepts and large language model fine-tuning processes is preferred.
  • Experience with data orchestration tools such as Apache Airflow is preferred.

About the company

C the Signs uses artificial intelligence to help healthcare professionals detect cancer earlier by analyzing patient symptoms, clinical data, and risk factors in real time to suggest diagnostic and referral pathways. It integrates into primary care and broader health system workflows, translating complex cancer guidelines into practical decisions across all cancer types, including rare ones. The platform supports faster referrals, reduces diagnostic delays, and enables more personalized cancer care while focusing on population health to identify disparities and align with national targets. Its goal is to improve patient outcomes by enabling earlier diagnosis and scalable, data-driven cancer care across health systems.

Company Size

11-50

Company Stage

Early VC

Total Funding

$14.7M

Headquarters

London, United Kingdom

Founded

2017

Get referred to C the Signs

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • March 2026 North East Essex launched AI case-finding for oesophageal and stomach cancers.
  • November 2025 studies showed 808% NHS ROI and 12% higher cancer detection.
  • April 2025 research across 1,084 GP practices found 20% more cancers, fewer urgent referrals.

What critics are saying

  • NHS procurement concentration leaves revenue exposed if ICB rollouts stall in 2026.
  • US expansion after January 2025 Khosla funding faces entrenched EHR competitors and sales cycles.
  • False negatives or adverse regulatory findings would destroy clinician trust and halt deployments.

What makes C the Signs unique

  • Founded by NHS doctors, C the Signs embeds directly into GP workflows.
  • By March 2026, it supported 1,500-plus GP practices and 11,000 clinicians.
  • Its AI uses real-world evidence to triage 100-plus cancer types within 60 seconds.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Stock Options

Flexible Work Hours

Hybrid Work Options

Remote Work Options

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Life Insurance

Paid Vacation

Paid Sick Leave

Paid Holidays

Growth & Insights and Company News

Headcount

6 month growth

-2%

1 year growth

-2%

2 year growth

-2%
Business Wire
Mar 19th, 2026
NHS launches first AI-driven early detection pathway for oesophageal and stomach cancers

A UK-first, AI-enabled pathway has launched in North East Essex to improve early detection of oesophageal and stomach cancers, which are among England's hardest cancers to diagnose early. Around four in five cases are currently diagnosed at advanced stages. Delivered by AstraZeneca, C the Signs, NHS Suffolk and North East Essex ICB, Health Innovation East and GP Primary Choice, the programme uses AI to analyse electronic health records and identify at-risk patients. Eligible patients receive SMS invitations to complete digital assessments, with high-risk cases triaged to appropriate diagnostics including capsule sponge testing or endoscopy. C the Signs already supports over 1,500 GP practices across England. The programme aligns with the National Cancer Plan's ambition to shift from reactive to predictive, risk-based approaches for cancers without established screening programmes.

FinSMEs
Jan 30th, 2025
C the Signs Raises $8M in Funding

C the Signs, a London, UK-based creator of an Artificial Intelligence (AI)-based platform to identify patients at risk of cancer at the earliest and most curable stage, raised $8M in funding

HIT Consultant
Jan 30th, 2025
C the Signs Raises $8M for U.S. Expansion

C the Signs, an AI-powered cancer detection company, raised $8M in a funding round led by Khosla Ventures to expand from the UK to the US. The company's platform analyzes EHRs to identify cancer risk early, improving survival rates. In the UK, it identified 20.7% of breast cancer cases up to five years earlier and improved early-stage ovarian cancer diagnosis by 53.3%. The funding aims to enhance early detection and personalized care in the US healthcare system.